Friday, 4 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus

View original at finance.yahoo.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus Major U.S. indexes like the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average rallied 2.4%, 1.8%, and 1.3%, respectively, during holiday-shortened trading last week…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks Focus List portfolio returned +29.54% in 2023 vs. +26.28% for S&P 500 and +13.61% for equal-weight S&P 500

    80% confidence

  • Zacks Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for S&P 500 and +11.4% for equal-weight version

    80% confidence

  • Fresh tariff threats to countries opposing acquisition of Greenland

    80% confidence

  • Zacks ECAP portfolio returned -2.3% in Q4 2025 vs. S&P 500's +2.7% gain

    80% confidence

  • Suggested a collaborative framework for Greenland during World Economic Forum at Davos summit

    80% confidence

  • Zacks ECAP returned +16.26% in 2024 vs. +24.89% for S&P 500

    80% confidence

  • Top 10 portfolio produced average annual return of +25.8% from 2012 through 2025 vs. +13.1% for S&P 500 and +10.5% for equal-weight version

    80% confidence

  • Zacks Focus List portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for equal-weight version

    80% confidence

  • Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight S&P 500

    80% confidence

  • Equal-weight portfolio of Zacks Rank #1 stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% vs. +10.85%)

    80% confidence

  • Hypothetical equal-weight portfolio returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index

    80% confidence

  • Over 10-year period (2016-2025), equal-weight Zacks Rank #1 stocks portfolio outperformed equal-weight S&P 500 by more than 7 percentage points (+18.55% vs. +11.65%)

    80% confidence

  • Zacks ECDP returned -0.6% in 2025 vs. +6.8% for NOBL

    80% confidence

  • Zacks Focus List portfolio returned -15.2% in 2022 vs. S&P 500's -17.96%

    80% confidence

  • Zacks Top 10 portfolio returned +62.98% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight version

    80% confidence

  • Zacks ECAP returned -1.67% for full year 2025 vs. S&P 500's +17.9% gain

    80% confidence

  • Zacks ECDP returned -2.1% in Q4 2025 vs. S&P 500's +2.7% gain and NOBL's +1.6% return

    80% confidence

  • Since 2012, Top 10 portfolio produced cumulative return of +2,472.7% vs. +561.6% for S&P 500 and +403.3% for equal-weight version

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus — Source | Via News | ViaNews EU